Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lianes

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancerF Cardenal, M P López-Cabrerizo, A Antón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 26, 2016
A consensus statement on the gender perspective in lung cancerD Isla, M Majem, N Viñolas, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2020
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer GroupJ Remon, E Nadal, M Dómine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisionsC Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancerF Cardenal, M P López-Cabrerizo, A Antón, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancerD Isla, C Sarries, R Rosell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 26, 2016
A consensus statement on the gender perspective in lung cancerD Isla, M Majem, N Viñolas, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2020
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer GroupJ Remon, E Nadal, M Dómine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisionsC Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 5